BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Krawczyk M, Mihalache F, Höblinger A, Acalovschi M, Lammert F, Zimmer V. Pancreatic cancer risk variant ABO rs505922 in patients with cholangiocarcinoma. World J Gastroenterol 2011; 17(41): 4640-4642 [PMID: 22147973 DOI: 10.3748/wjg.v17.i41.4640]
URL: https://www.wjgnet.com/1007-9327/full/v17/i41/4640.htm
Number Citing Articles
1
Seth K Rummel, Rachel E Ellsworth. The role of the histoblood ABO group in cancerFuture Science OA 2016; 2(2) doi: 10.4155/fsoa-2015-0012
2
Guanwu Wang, Lara Rosaline Heij, Dong Liu, Edgar Dahl, Sven Arke LANG, Tom Florian Ulmer, Tom LUEDDE, Ulf Peter Neumann, Jan Bednarsch. The Role of Single-Nucleotide Polymorphisms in Cholangiocarcinoma: A Systematic ReviewCancers 2022; 14(23): 5969 doi: 10.3390/cancers14235969
3
Yanxia Li, Luyang Liu, Yubei Huang, Hong Zheng, Lian Li. Association of ABO polymorphisms and pancreatic Cancer/ Cardiocerebrovascular disease: a meta-analysisBMC Medical Genetics 2020; 21(1) doi: 10.1186/s12881-020-0975-8
4
Yun-Fei Duan, Feng Zhu, Xiao-Dong Li, Yong An, Hanze Zhang, Yebin Zhou, Xiaofei Zhang, Yong Jiang. Association between ABO gene polymorphism (rs505922) and cancer risk: a meta-analysisTumor Biology 2015; 36(7): 5081 doi: 10.1007/s13277-015-3159-y